Q

66. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: A clinical perspective. Endocrine Rev 2001; 22:36-52.

67. Zeng G, Nystrom FH, Ravichandran LV, Cong L-N, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI 3-kinase, and Akt in insulin-signaling pathways related to production of nitris oxide in human vascular endothelial cells. Circulation 2000; 101:1539-1545.

68. Thomas GD, Ahang W, Victor RG. Nitric oxide deficiency as a cause of clinical hypertension: Promising new drug targets for refractory hypertension. JAMA 2001; 285:2055-2057.

69. Tooke JE. Endotheliopathy precedes type 2 diabetes. Diabetes Care 1998; 21:20472049.

70. Yudkin JS, Panahloo A, Stehouwer C, Emeis JJ, Bulmer K, Mohamed-Ali V, Denver AE. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects. Diabetologia 2000; 43:1099-1106.

71. Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care 1999; 22(suppl 3):C25-C30.

72. Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complications 2001; 15:44-54.

73. Meigs JBJ, Mittleman MA, Nthan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PWF. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study. JAMA 2000; 283:221-228.

74. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282:2131-2135.

75. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102:42-47.

76. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000; 58:1703-1710.

77. Feingold KR, Grunfeld C, Pang M, Doerrier W, Krauss RM. LDL subclass pheno-types and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 1992; 12:1496-1502.

78. Festa A, D'Agostino R Jr, Mykkanen L, Tracy RP, Hales CN, Howard BV, Haffner SM. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. Diabetes Care 1999; 22:1688-1693.

79. Ginsberg HN, Tuck C. Diabetes and dyslipidemia. In: Lebovitz HE, ed. Educational Review Manual in Endocrinology and Metabolism. New York: Castle Connolly Graduate Medical Publishing, 2000:1-47.

80. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The Insulin Resistance Atherosclerosis Study. Diabetes 1998; 47:793-800.

81. Wagenknecht LE, D'Agostino RB Jr, Haffner SM Savage PJ, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: The Insulin Resistance

Atherosclerosis Study. Diabetes Care 1998; 21:1812-1818. f

82. Laakso M, Ronnemaa T, Lehto S, Puukka P, Kallio V, Pyoräla K. Does NIDDM

Supplements For Diabetics

Supplements For Diabetics

All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.

Get My Free Ebook


Post a comment